Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2019 Volume 20 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2019 Volume 20 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

MicroRNA‑21 contributes to the puerarin‑induced cardioprotection via suppression of apoptosis and oxidative stress in a cell model of ischemia/reperfusion injury

  • Authors:
    • Hai‑Xiang Xu
    • Wen Pan
    • Jian‑Feng Qian
    • Feng Liu
    • Hai‑Qi Dong
    • Qing‑Jun Liu
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, Jiangsu 215300, P.R. China
  • Pages: 719-727
    |
    Published online on: May 22, 2019
       https://doi.org/10.3892/mmr.2019.10266
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Puerarin, a major bioactive constituent of the Radix puerariae, can ameliorate myocardial ischemia/reperfusion (I/R) injury. Emerging evidence supports that microRNA (miR)‑21 functions as a protective factor against I/R and/or hypoxia‑reperfusion (H/R)‑induced myocardial injury. However, the role of miR‑21 in the cardioprotective effect of puerarin remains unclear. Therefore, the purpose of the present study was to demonstrate the involvement of miR‑21 in the cardioprotective mechanisms of puerarin using a cell model of I/R injury, generated by culturing rat H9c2 cardiomyocytes under H/R conditions. The results demonstrated that pre‑treatment with puerarin significantly increased cell viability, decreased lactate dehydrogenase activity and upregulated miR‑21 expression in H/R‑treated H9c2 cells. Transfection of an miR‑21 inhibitor led to an increase in H/R‑induced cytotoxicity and reversed the protective effects of puerarin. Additionally, miR‑21 inhibition attenuated the puerarin‑induced decrease in the rate of apoptosis, caspase‑3 activity and the expression of apoptosis regulator Bax, and increased apoptosis regulator Bcl‑2 expression, under H/R conditions. Furthermore, puerarin mitigated H/R‑induced oxidative stress as evidenced by the decrease in endogenous reactive oxygen species production, malondialdehyde content and NADPH oxidase 2 expression, and enhanced the antioxidative defense system as illustrated by the increase in superoxide dismutase activity, catalase and glutathione peroxidase levels. These effects were all eliminated by miR‑21 inhibitor transfection. Furthermore, the miR‑21 inhibitor exacerbated the H/R‑induced oxidative stress and attenuated the antioxidative defense system in H/R‑treated H9c2 cells. Taken together, the results suggested that miR‑21 mediated the cardioprotective effects of puerarin against myocardial H/R injury by inhibiting apoptosis and oxidative stress.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Turer AT and Hill JA: Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 106:360–368. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Thind GS, Agrawal PR, Hirsh B, Saravolatz L, Chen-Scarabelli C, Narula J and Scarabelli TM: Mechanisms of myocardial ischemia-reperfusion injury and the cytoprotective role of minocycline: Scope and limitations. Future Cardiol. 11:61–76. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Yang Q, He GW, Underwood MJ and Yu CM: Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: Perspectives and implications for postischemic myocardial protection. Am J Transl Res. 8:765–777. 2016.PubMed/NCBI

4 

Liu B, Tan Y, Wang D and Liu M: Puerarin for ischaemic stroke. Cochrane Database Syst Rev. 2:CD0049552016.PubMed/NCBI

5 

Wei SY: Progress on cardiovascular protections and mechanism research of puerarin. Zhongguo Zhong Yao Za Zhi. 40:2278–2284. 2015.(In Chinese). PubMed/NCBI

6 

Tang H, Song X, Ling Y, Wang X, Yang P, Luo T and Chen A: Puerarin attenuates myocardial hypoxia/reoxygenation injury by inhibiting autophagy via the Akt signaling pathway. Mol Med Rep. 15:3747–3754. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Wenjun H, Jing W, Tao L, Ling M, Yan Y, Xiaorong Z and Rui Z: The protective effect of puerarin on myocardial infarction reperfusion injury (MIRI): A meta-analysis of randomized studies in rat models. Med Sci Monit. 21:1700–1706. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Guo BQ, Xu JB, Xiao M, Ding M and Duan LJ: Puerarin reduces ischemia/reperfusion-induced myocardial injury in diabetic rats via upregulation of vascular endothelial growth factor A/angiotensin-1 and suppression of apoptosis. Mol Med Rep. 17:7421–7427. 2018.PubMed/NCBI

9 

Gao Q, Pan HY, Bruce IC and Xia Q: Improvement of ventricular mechanical properties by puerarin involves mitochondrial permeability transition in isolated rat heart during ischemia and reperfusion. Conf Proc IEEE Eng Med Biol Soc. 6:5591–5594. 2005.PubMed/NCBI

10 

Ambros V: MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing. Cell. 113:673–676. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Koroleva IA, Nazarenko MS and Kucher AN: Role of microRNA in development of instability of atherosclerotic plaques. Biochemistry (Mosc). 82:1380–1390. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Pordzik J, Pisarz K, De Rosa S, Jones AD, Eyileten C, Indolfi C, Malek L and Postula M: The potential role of platelet-related microRNAs in the development of cardiovascular events in high-risk populations, including diabetic patients: A review. Front Endocrinol (Lausanne). 9:742018. View Article : Google Scholar : PubMed/NCBI

13 

Yang Q, Yang K and Li A: microRNA-21 protects against ischemia-reperfusion and hypoxia-reperfusion-induced cardiocyte apoptosis via the phosphatase and tensin homolog/Akt-dependent mechanism. Mol Med Rep. 9:2213–2220. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Zhu H and Fan GC: Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc Res. 94:284–292. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Gu GL, Xu XL, Sun XT, Zhang J, Guo CF, Wang CS, Sun B, Guo GL, Ma K, Huang YY, et al: Cardioprotective effect of MicroRNA-21 in murine myocardial infarction. Cardiovasc Ther. 33:109–117. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Han Q, Zhang HY, Zhong BL, Zhang B and Chen H: Antiapoptotic effect of recombinant HMGB1 A-box protein via regulation of microRNA-21 in myocardial ischemia-reperfusion injury model in rats. DNA Cell Biol. 35:192–202. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Qin Y, Yu Y, Dong H, Bian X, Guo X and Dong S: MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis. Int J Med Sci. 9:413–423. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Yang Q, Yang K, Li A and Tan W: Anti-apoptosis and expression of microRNA-21 in rat myocardium during early ischemia-reperfusion injury. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 38:483–489. 2013.(In Chinese). PubMed/NCBI

19 

Cheng Y and Zhang C: MicroRNA-21 in cardiovascular disease. J Cardiovasc Transl Res. 3:251–255. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, Chun B, Zhuang J and Zhang C: Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res. 87:431–439. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

22 

Mirzayans R, Andrais B, Kumar P and Murray D: The growing complexity of cancer cell response to DNA-damaging agents: Caspase 3 mediates cell death or survival? Int J Mol Sci. 17:E7082016. View Article : Google Scholar : PubMed/NCBI

23 

Sinning C, Westermann D and Clemmensen P: Oxidative stress in ischemia and reperfusion: Current concepts, novel ideas and future perspectives. Biomark Med. 11:11031–11040. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Becker BF, Massoudy P, Permanetter B, Raschke P and Zahler S: Possible significance of free oxygen radicals for reperfusion injury. Z Kardiol. 5 (Suppl 82):49–58. 1993.(In German).

25 

Xie B, Wang Q, Zhou C, Wu J and Xu D: Efficacy and safety of the injection of the traditional chinese medicine puerarin for the treatment of diabetic peripheral neuropathy: A systematic review and meta-analysis of 53 randomized controlled trials. Evid Based Complement Alternat Med. 2018:28346502018. View Article : Google Scholar : PubMed/NCBI

26 

Ye Y, Perez-Polo JR, Qian J and Birnbaum Y: The role of microRNA in modulating myocardial ischemia-reperfusion injury. Physiol Genomics. 43:534–542. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Fliss H and Gattinger D: Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 79:949–956. 1996. View Article : Google Scholar : PubMed/NCBI

28 

Yellon DM and Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI

29 

Li W, Lu M, Zhang Y, Xia D, Chen Z, Wang L, Yin N and Wang Z: Puerarin attenuates the daunorubicin-induced apoptosis of H9c2 cells by activating the PI3K/Akt signaling pathway via the inhibition of Ca2+ influx. Int J Mol Med. 40:1889–1894. 2017.PubMed/NCBI

30 

Ling C, Liang J, Zhang C, Li R, Mou Q, Qin J, Li X and Wang J: Synergistic effects of salvianolic acid B and puerarin on cerebral ischemia reperfusion injury. Molecules. 23:E5642018. View Article : Google Scholar : PubMed/NCBI

31 

Liu Y, Tang Q, Shao S, Chen Y, Chen W and Xu X: Lyophilized powder of catalpol and puerarin protected cerebral vessels from ischemia by its anti-apoptosis on endothelial cells. Int J Biol Sci. 13:327–338. 2017. View Article : Google Scholar : PubMed/NCBI

32 

Kang Z, Li Z, Huang P, Luo J, Liu P, Wang Y, Xia T and Zhou Y: Remote ischemic preconditioning upregulates microRNA-21 to protect the kidney in children with congenital heart disease undergoing cardiopulmonary bypass. Pediatr Nephrol. 33:911–919. 2018. View Article : Google Scholar : PubMed/NCBI

33 

Richart A, Loyer X, Neri T, Howangyin K, Guérin CL, Ngkelo A, Bakker W, Zlatanova I, Rouanet M, Vilar J, et al: MicroRNA-21 coordinates human multipotent cardiovascular progenitors therapeutic potential. Stem Cells. 32:2908–2922. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Gross A: BCL-2 family proteins as regulators of mitochondria metabolism. Biochim Biophys Acta. 1857:1243–1246. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Song XB, Liu G, Wang ZY and Wang L: Puerarin protects against cadmium-induced proximal tubular cell apoptosis by restoring mitochondrial function. Chem Biol Interact. 260:219–231. 2016. View Article : Google Scholar : PubMed/NCBI

36 

Liu Y, Ren L, Liu W and Xiao Z: MiR-21 regulates the apoptosis of keloid fibroblasts by caspase-8 and mitochondrial-mediated apoptotic signaling pathway via targeting fasL. Biochem Cell Biol. 96:548–555. 2018. View Article : Google Scholar : PubMed/NCBI

37 

Wu H, Wang J, Ma H, Xiao Z and Dong X: MicroRNA-21 inhibits mitochondria-mediated apoptosis in keloid. Oncotarget. 8:92914–92925. 2017.PubMed/NCBI

38 

Li X, Cai W, Lee K, Liu B, Deng Y, Chen Y, Zhang X, He JC and Zhong Y: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes. Sci Rep. 7:146032017. View Article : Google Scholar : PubMed/NCBI

39 

Wang T, Liu Y, Huang C, Mansai HAA, Wei W, Zhang X, Li X, Liu S and Yang S: Puerarin promotes MIN6 cell survival by reducing cellular reactive oxygen species. Mol Med Rep. 17:7281–7286. 2018.PubMed/NCBI

40 

Zhou X, Bai C, Sun X, Gong X, Yang Y, Chen C, Shan G and Yao Q: Puerarin attenuates renal fibrosis by reducing oxidative stress induced-epithelial cell apoptosis via MAPK signal pathways in vivo and in vitro. Ren Fail. 39:423–431. 2017. View Article : Google Scholar : PubMed/NCBI

41 

Gang C, Qiang C, Xiangli C, Shifen P, Chong S and Lihong L: Puerarin suppresses angiotensin II-induced cardiac hypertrophy by inhibiting NADPH oxidase activation and oxidative stress-triggered AP-1 signaling pathways. J Pharm Pharm Sci. 18:235–248. 2015. View Article : Google Scholar : PubMed/NCBI

42 

Wei C, Li L, Kim IK, Sun P and Gupta S: NF-κB mediated miR-21 regulation in cardiomyocytes apoptosis under oxidative stress. Free Radic Res. 48:282–291. 2014. View Article : Google Scholar : PubMed/NCBI

43 

Zuo L, Zhou T, Pannell BK, Ziegler AC and Best TM: Biological and physiological role of reactive oxygen species - the good, the bad and the ugly. Acta Physiol (Oxf). 214:329–348. 2015. View Article : Google Scholar : PubMed/NCBI

44 

Zhou T, Prather ER, Garrison DE and Zuo L: Interplay between ROS and antioxidants during ischemia-reperfusion injuries in cardiac and skeletal muscle. Int J Mol Sci. 19:E4172018. View Article : Google Scholar : PubMed/NCBI

45 

Ma Y, Gai Y, Yan J, Li J and Zhang Y: Puerarin attenuates anoxia/reoxygenation injury through enhancing Bcl-2 associated athanogene 3 expression, a modulator of apoptosis and autophagy. Med Sci Monit. 22:977–983. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu HX, Pan W, Qian JF, Liu F, Dong HQ and Liu QJ: MicroRNA‑21 contributes to the puerarin‑induced cardioprotection via suppression of apoptosis and oxidative stress in a cell model of ischemia/reperfusion injury. Mol Med Rep 20: 719-727, 2019.
APA
Xu, H., Pan, W., Qian, J., Liu, F., Dong, H., & Liu, Q. (2019). MicroRNA‑21 contributes to the puerarin‑induced cardioprotection via suppression of apoptosis and oxidative stress in a cell model of ischemia/reperfusion injury. Molecular Medicine Reports, 20, 719-727. https://doi.org/10.3892/mmr.2019.10266
MLA
Xu, H., Pan, W., Qian, J., Liu, F., Dong, H., Liu, Q."MicroRNA‑21 contributes to the puerarin‑induced cardioprotection via suppression of apoptosis and oxidative stress in a cell model of ischemia/reperfusion injury". Molecular Medicine Reports 20.1 (2019): 719-727.
Chicago
Xu, H., Pan, W., Qian, J., Liu, F., Dong, H., Liu, Q."MicroRNA‑21 contributes to the puerarin‑induced cardioprotection via suppression of apoptosis and oxidative stress in a cell model of ischemia/reperfusion injury". Molecular Medicine Reports 20, no. 1 (2019): 719-727. https://doi.org/10.3892/mmr.2019.10266
Copy and paste a formatted citation
x
Spandidos Publications style
Xu HX, Pan W, Qian JF, Liu F, Dong HQ and Liu QJ: MicroRNA‑21 contributes to the puerarin‑induced cardioprotection via suppression of apoptosis and oxidative stress in a cell model of ischemia/reperfusion injury. Mol Med Rep 20: 719-727, 2019.
APA
Xu, H., Pan, W., Qian, J., Liu, F., Dong, H., & Liu, Q. (2019). MicroRNA‑21 contributes to the puerarin‑induced cardioprotection via suppression of apoptosis and oxidative stress in a cell model of ischemia/reperfusion injury. Molecular Medicine Reports, 20, 719-727. https://doi.org/10.3892/mmr.2019.10266
MLA
Xu, H., Pan, W., Qian, J., Liu, F., Dong, H., Liu, Q."MicroRNA‑21 contributes to the puerarin‑induced cardioprotection via suppression of apoptosis and oxidative stress in a cell model of ischemia/reperfusion injury". Molecular Medicine Reports 20.1 (2019): 719-727.
Chicago
Xu, H., Pan, W., Qian, J., Liu, F., Dong, H., Liu, Q."MicroRNA‑21 contributes to the puerarin‑induced cardioprotection via suppression of apoptosis and oxidative stress in a cell model of ischemia/reperfusion injury". Molecular Medicine Reports 20, no. 1 (2019): 719-727. https://doi.org/10.3892/mmr.2019.10266
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team